INTRODUCTION
Mammalian atrial extracts have been shown to have potent vasorelaxant, diuretic and natriuretic effects in vivo [1, 2] . Atrial natriuretic factor (ANF), stored within atrial secretory granules, is released into the circulation in response to volume expansion and participates in the maintenance ofcardiovascular homoeostasis by affecting kidney function and vascular resistance [3] [4] [5] . ANF appears to mediate these responses by selectively activating, at its target tissue, particulate guanylate cyclase, the enzyme catalysing the formation of cGMP from GTP [6] [7] [8] [9] [10] [11] [12] [13] . Specific receptors for ANF have been demonstrated in kidney, adrenal cortex and vascular smooth muscle [6, 7, 8, 14, 15] . Using vascular smooth muscle, Napier et al. [16] have shown a good corrrelation between the apparent dissociation constant (Kd) for the binding with the half-maximal concentration for vasorelaxation of several biologically active ANF analogues. These data suggest that these receptors are responsible for mediating the physiological actions of ANF on vascular tissue.
The mechanisms of hormonal regulation of cell function have elicited much interest. Protein phosphorylations mediated by specific cellular kinases are regarded as important physiological control mechanisms. Among the different kinases that are extensively studied, protein kinase C is a widespread Ca2+-phospholipiddependent enzyme which is activated in vivo by diacylglycerol, one of the products of hormone-receptorinduced hydrolysis of polyphosphoinositides [17, 18] . Evidence indicates that tumour-promoting phorbol esters can substitute for diacylglycerol in vitro and in intact cells to activate protein kinase C in the absence of receptor-mediated hydrolysis of polyphosphoinositides [19] .
We have previously reported that, in rat aortic smooth-muscle cells in culture (A-10, A.T.C.C. CRL 1476), vasopressin stimulated phosphatidylinositol turnover [20] and inhibited isoprenaline-and ANF-induced cAMP and cGMP accumulation respectively [21, 7] . In addition, pretreatment of these cells with tumourpromoting phorbol esters attenuated isoprenalineinduced cAMP accumulation and vasopressin-stimulated phosphatidylinositol turnover [22] . Addition of vasopressin to the PDBu-pretreated cells did not produce any additive inhibitory effect, suggesting that both may be acting at the same site. In the present work we have examined the effects of protein kinase C activation on the regulation of ANF-receptor-mediated cGMP accumulation in these cells.
EXPERIMENTAL

Materials
cGMP radioimmunoassay kits and 125I-ANF (sp. radioactivity 2200 Ci/mmol) were purchased from New England Nuclear. PDBu, aPDD and IBMX were from Sigma. ANF II (fragment 5-27) was from Sigma and Calbiochem-Behring.
Culture of smooth-muscle cells
Rat aortic vascular smooth-muscle cells (line A-10; A.T.C.C., CRL 1476) were obtained from the American Type Culture Collection and cultured in Dulbecco's Modified Eagle's Medium plus 20% (v/v) fetal bovine serum as described previously [21] . Phorbol ester pretretment and cGMP determination
The cells were incubated in 1 ml of fresh medium with the phorbol esters for the times indicated. Subsequently, the cells were washed three times with Dulbecco's phosphate-buffered saline containing 10 mM-MgCl2, 0.1% glucose and 0.2% bovine serum albumin (DPBS).
The cells were incubated with 1 ,pM-ANF with or without Vol. 244
Abbreviations used: ANF, atrial natriuretic factor; cGMP, cyclic GMP; cAMP, cyclic AMP; PDBu, phorbol 12,13-dibutyrate; aPDD, 4a-phorbol 12,13-didecanoate; IBMX, 3-isobutyl-1-methylxanthine. 10 nM-[arginine]vasopressin in DPBS containing 0.5 mM-IBMX for 10 min at 37 'C. cGMP was extracted as previously described [7] and determined by radioimmunoassay. '251-ANF binding to A-10-cell membranes A-10 cell membranes were prepared as described previously [23] . The final resuspension buffer (Buffer A) contained 50 mM-Tris, 1 mM-EDTA, 150 mM-NaCl, 5 mM-MgCl2, pH 7.4. The cell membranes (15-25 ,g of protein) were incubated for 60 min at 25 'C with increasing concentrations of 125I-ANF (15 c.p.m./fmol) in 500 pl of Buffer A in the absence (total) and presence (non-specific) of 1 /LM-ANF II. The reaction was stopped with 3 ml of ice-cold Buffer A. Bound and free ligand were separated by filtering through Whatman GF/C filters (presoaked in 0.3% polyethyleneimine) and washing the filters with 3 x 3 ml of cold Buffer A. All incubations were performed in silicone-treated 'glass tubes.
All experiments were performed in triplicate and repeated at least twice. Data from representative experiments + S.E.M. are presented.
RESULTS
Exposure of A-10 cells to 1 gM-ANF in the presence of IBMX resulted in an 12-15-fold increase in cGMP accumulation. Pretreatment of these cells with 1 ,tM-PDBu at 37 'C inhibited ANF-stimulated cGMP 120 r accumulation. This inhibitory effect was observed as early as 2 min (30% inhibition) after preincubation with PDBu ( Fig. 1) , the shortest incubation time used. Up to 20 min pretreatment with aPDD, a non-tumourpromoting phorbol ester, had no effect on ANFstimulated cGMP accumulation. PDBu did not decrease basal cGMP concentrations (Fig. 1) . The dose-response relationship of phorbol ester pretreatment on ANFstimulated cGMP accumulation is shown in Fig. 2 . At concentrations as low as 1 nM, PDBu inhibited ANFstimulated cGMP accumulation (12% at 1 nm and 63% at 1 M). The EC50 (concn. giving half-maximal effect) was about 10 nM-PDBu. The effects of pretreatment with 10 nM-PDBu or 100 nM-aPDD on cGMP accumulation induced by various concentrations of ANF are shown in Fig. 3 . At all concentrations of ANF, PDBu inhibited cGMP formation (by 12+2%, 28 + 2% and 38 +±4% at 0.01 LM-, 0.1 /zM-and 1 #M-ANF respectively), whereas aPDD was without effect.
To identify the site of PDBu action, binding experiments were performed with 1251-ANF and control and PDBu-treated cell membranes. 125I-ANF specifically bound to control membranes in a saturable manner, with an apparent Kd of 1.8+0. with 1 ,tM-ANF (, A*) and continued for O min at 37 'C. The assay was terminated by addition of 100 p1 of 100% trichloroacetic acid (ice-cold), and cGMP was extracted and assayed by radioimmunoassay as described [7] . Data presented are means + S.E.M. from one experiment done in triplicate, which is representative of three experiments. cultured vascular smooth-muscle cells with PDBu, an activator of protein kinase C, resulted in an attenuation of ANF-stimulated cGMP accumulation without affecting basal cGMP concentrations. This effect of PDBu was time-and dose-dependent, and probably mediated by activation of protein kinase C, because aPDD, which does not activate protein kinase C, was ineffective. Zwiller et al. [24] have reported that protein kinase C catalyses the phosphorylation of rat brain soluble guanylate cyclase, resulting in increased enzyme activity. From these and our data it appears that protein kinase C modulates the activities of membrane-bound and soluble guanylate cyclase differently. We cannot test the effect of phorbol esters on soluble guanylate cyclase, because the A-10 cells lack this enzyme [7] .
Attenuation of ANF-stimulated cGMP accumulation by PDBu could be caused either at the ANF receptor or at a post-receptor site by activated protein kinase C.
PhosphQrylation of ,-and a,-adrenergic receptors by protein kinase C has been shown to decrease cAMP production and phosphatidylinositol turnover in avian erythrocytes [25, 26] and DDT/MF2 smooth-muscle cells [27] respectively. It has also been shown that phorbol esters decreased binding of epidermal growth factor in A-43 1 cells [28] , that of a,-adrenergic ligands in hepatocytes (29] , and insulin binding in U937 and HL-60 cells [30, 31] . In contrast, they did not affect binding of vasopressin to hepatocytes [29] and A-10 cells [22] , angiotensin II to smooth-muscle cells [32] , chemotactic peptides to neutrophils [33] , or insulin to cultured hepatoma cells [34] . Our studies also show that PDBu had no significant effect on 1251-ANF binding to A-10 cell membranes, suggesting that the inhibitory effect may be at a post-receptor site.
The inhibition by PDBu of ANF-stimulated cGMP accumulation probably did not result from stimulation of phosphodiesterase activity, since all the experiments were performed in the presence of IBMX, a potent phosphodiesterase inhibitor.
The mechanism by which ANF stimulates particulate guanylate cyclase is not known. Kuno et al. [35] have suggested that, in rat lung, the ANF receptor and particulate guanylate cyclase activity are contained in a single transmembrane glycoprotein. However, Ishido et al. [36] have demonstrated that in bovine lung the ANF receptor and guanylate cyclase are separate proteins that are tightly associated. Although the precise mechanism underlying the inhibitory effects of protein kinase C is not known at present, it is tempting to hypothesize that protein kinase C might stimulate phosphorylation of a key regulatory protein in the ANF/cGMP pathway, thus inhibiting the relaxation induced by ANF.
